We are live on ! Find out more
TCM

TimesSquare Capital Management Portfolio holdings

AUM $6.8B
1-Year Est. Return 45.85%
This Fund
S&P 500
This Quarter Est. Return
+3.2%
1 Year Est. Return
+45.85%
3 Year Est. Return
+131.54%
5 Year Est. Return
+149.79%
10 Year Est. Return
+765.84%
AUM
$7.19B
AUM Growth
+$18.8M
Cap. Flow
-$40.8M
Cap. Flow %
-0.57%
Top 10 Hldgs %
14.72%
Holding
203
New
14
Increased
81
Reduced
93
Closed
14

Top Buys

Rank Stock Value
1
APTV icon
Aptiv
APTV
+$67.6M
2
ROST icon
Ross Stores
ROST
+$52.8M
3
IDXX icon
Idexx Laboratories
IDXX
+$47.9M
4
AZPN
Aspen Technology Inc
AZPN
+$45.8M
5
LEGN icon
Legend Biotech
LEGN
+$39.9M

Top Sells

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$61M
2
TRU icon
TransUnion
TRU
+$56.2M
3
PCAR icon
PACCAR
PCAR
+$51.6M
4
SAIL
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
+$48.3M
5
CRL icon
Charles River Laboratories
CRL
+$43.4M

Sector Composition

Rank Sector Weight
1 Technology 27.74%
2 Industrials 20.24%
3 Healthcare 17.35%
4 Consumer Discretionary 13.22%
5 Financials 7.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SMPL icon
76
Simply Good Foods
SMPL
$956M
$41.3M 0.57%
1,291,390
+223,686
+21% +$7.34M
INSP icon
77
Inspire Medical Systems
INSP
$1.73B
$41.2M 0.57%
232,520
+22,905
+11% +$4.6M
ITCI
78
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$41.2M 0.57%
885,510
+84,672
+11% +$4.42M
BTRS
79
DELISTED
BTRS Holdings Inc. Class 1 Common Stock
BTRS
$40.8M 0.57%
4,407,508
-340,835
-7% -$2.21M
RRX icon
80
Regal Rexnord
RRX
$11.5B
$40.7M 0.57%
290,010
-1,311
-0.5% -$176K
HXL icon
81
Hexcel
HXL
$7.63B
$40.5M 0.56%
783,720
-22,665
-3% -$1.32M
ONTO icon
82
Onto Innovation
ONTO
$14.3B
$40M 0.56%
623,735
-62,415
-9% -$4.59M
FND icon
83
Floor & Decor
FND
$6.3B
$39.7M 0.55%
564,400
-122,510
-18% -$9.83M
AZEK
84
DELISTED
The AZEK Co
AZEK
$39.4M 0.55%
2,370,370
+415,800
+21% +$7.91M
ESAB icon
85
ESAB
ESAB
$5.32B
$39.2M 0.55%
1,175,510
+374,300
+47% +$15.3M
MTSI icon
86
MACOM Technology Solutions
MTSI
$22.7B
$39M 0.54%
753,220
-143,790
-16% -$7.87M
PINS icon
87
Pinterest
PINS
$13.8B
$38.5M 0.54%
1,653,200
+455,700
+38% +$10M
LEGN icon
88
Legend Biotech
LEGN
$4B
$38.4M 0.53%
941,300
+849,800
+929% +$39.9M
PLNT icon
89
Planet Fitness
PLNT
$3.7B
$38.4M 0.53%
665,400
+2,785
+0.4% +$201K
NEWR
90
DELISTED
New Relic, Inc.
NEWR
$38M 0.53%
661,842
-35,160
-5% -$2.11M
FOCS
91
DELISTED
Focus Financial Partners Inc. Class A
FOCS
$38M 0.53%
1,204,750
-186,690
-13% -$7.12M
ATRC icon
92
AtriCure
ATRC
$2.12B
$37.7M 0.52%
964,530
+61,951
+7% +$2.83M
CPAY icon
93
Corpay
CPAY
$26.3B
$37M 0.51%
210,100
+21,600
+11% +$4.63M
PTCT icon
94
PTC Therapeutics
PTCT
$6.23B
$36.7M 0.51%
731,890
+45,990
+7% +$2.25M
VCTR icon
95
Victory Capital Holdings
VCTR
$6.85B
$36.7M 0.51%
1,575,859
+159,360
+11% +$4.23M
VC icon
96
Visteon
VC
$2.8B
$35.7M 0.5%
336,400
-131,475
-28% -$15.7M
TPG icon
97
TPG
TPG
$7.93B
$35.4M 0.49%
1,271,700
-29,100
-2% -$841K
WHD icon
98
Cactus
WHD
$5.7B
$34.9M 0.49%
908,990
+272,970
+43% +$10.9M
TTEK icon
99
Tetra Tech
TTEK
$8.97B
$34.5M 0.48%
1,343,000
+78,000
+6% +$2.18M
SPT icon
100
Sprout Social
SPT
$609M
$34.1M 0.47%
562,614
+71,705
+15% +$4.31M
2 3
4
5 6

Similar funds

CF
Cantor Fitzgerald New York $6.78B AUM 28.97% 1-Year Est. Return
JCAM
Jericho Capital Asset Management New York $6.76B AUM 88.1% 1-Year Est. Return
GAM
Groupama Asset Management Paris, France $6.85B AUM 43.37% 1-Year Est. Return
CIMLRA
CBRE Investment Management Listed Real Assets Radnor, Pennsylvania $6.75B AUM 8.88% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
SPS
Susquehanna Portfolio Strategies Bala Cynwyd, Pennsylvania $6.73B AUM 45.57% 1-Year Est. Return
BHM
Briar Hall Management Nashville, Tennessee $6.72B AUM 4.95% 1-Year Est. Return
MSE
MUFG Securities EMEA London, United Kingdom $6.7B AUM 32.3% 1-Year Est. Return

TimesSquare Capital Management's Q3 2022 Portfolio in Review

As of Q3 2022, TimesSquare Capital Management held 203 positions worth $7.19B, up 0.26% from $7.17B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

TimesSquare Capital Management's Q3 2022 filing shows 14 new, 81 increased, 93 reduced and 14 closed positions. Its largest new stake was Aptiv: 704,300 shares worth $55.1M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $61M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 28% a quarter earlier, followed by Industrials and Healthcare.

  • TimesSquare Capital Management's largest Q3 2022 buy was Aptiv: 704,300 shares worth $55.1M.
  • TimesSquare Capital Management added most to Idexx Laboratories in Q3 2022, an estimated $47.9M increase.
  • TimesSquare Capital Management's biggest Q3 2022 reduction was TransUnion, cutting an estimated $56.2M.
  • TimesSquare Capital Management fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2022, selling an estimated $61M.
  • TimesSquare Capital Management's ten largest holdings make up 15% of its $7.19B portfolio in Q3 2022.
  • TimesSquare Capital Management opened 14 new positions and closed 14 in Q3 2022.
  • TimesSquare Capital Management's portfolio value rose 0.26% quarter-over-quarter to $7.19B.

Based on TimesSquare Capital Management's 13F filing for Q3 2022, filed 9 Nov 2022.